Carolyn Carrera, MD - Trinity Health IHA Medical Group, Hematology Oncology-Ann Arbor Campus

Dr. Tom Regenbogen is a board-certified physician specializing in hematology and medical oncology, affiliated with Trinity Health IHA Medical Group in Ypsilanti, Michigan. He focuses on the diagnosis and management of cancer and blood disorders, bringing extensive clinical expertise to his practice. Dr. Regenbogen completed his medical education at University College Dublin in Ireland and underwent residency and fellowship training at Washington University School of Medicine. He is recognized for his contributions to the field as a member of the American Society of Clinical Oncology. Generated from the website

Radhika Takia, MD is a board-certified in Hematology and Oncology.

Elie G. Dib, MD, MS, FACP, is board-certified in hematology and medical oncology. He has a special interest in treating cancer with innovative therapies including immunotherapy and targeted therapy. Dr. Dib completed his postgraduate education at Harvard Medical School in cancer biology research with a special focus on cancer immunotherapy and genomics. He also holds a Master of Science in Individualized Genomics and Health from Johns Hopkins University. Dr. Dib treats patients with a variety of malignancies especially malignant hematological diseases (including lymphoma, multiple myeloma, leukemia, myelodysplastic syndrome and other bone marrow disorders) as well as other tumors including breast cancer, melanoma, lung cancer, head and neck cancers, gastrointestinal cancers, sarcomas and urologic cancers. He is a fellow of the American College of Physicians and serves as the associate program director for the Hematology Oncology Fellowship at Trinity Health Ann Arbor Hospital. Dr. Dib is an Adjunct Faculty Lecturer at Johns Hopkins University where he teaches Cancer Genomics